BCL6 and neoplasm: Since Bcl6 controls Th2 activity of Treg cells by inhibiting Gata347, and represses ST2 expression in Treg cells in a cell-intrinsic manner48, we explored this lineage-defining transcription factor and associated accessory Blimp1 transcription factor in the liquid tumor context.